Outcomes4Me is a founding member of CancerX, an initiative of the Cancer Moonshot Learn more >

/ for-oncology-care-providers
The United States is currently facing a severe shortage of two life-saving chemotherapy drugs –...
There are a lot of misconceptions about clinical trials but the reality is that these...
Labcorp’s Dr. Rebecca Previs, an oncologist and recognized leader in the oncology diagnostics field, joined...
We’re excited to announce that Outcomes4Me now includes non-small cell lung cancer (NSCLC) as a...
Last weekend, the Outcomes4Me team had the honor of attending Living Beyond Breast Cancer’s (LBBC)...
April is National Minority Cancer Awareness & Health Month, an initiative led by the National...
Every April 16th, the healthcare community commemorates National Healthcare Decisions Day (NHDD), with some institutions...
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 32 leading cancer centers...
Dr. Sara Tolaney, the Chief of the Breast Oncology Division at Dana Farber Cancer Institute,...
Healthcare organizations typically look at patient engagement–combined with treatment adherence and outcomes–as key measures of...